TLX66 Meets Study Objectives, Holding Out in AL Amyloidosis Telix Pharmaceuticals reported the results from the TRALA trial (Targeted Radiotherapy for AL Amyloidosis), a Phase I/IIa trial evaluatin...
The introduction of antibiotics subsequently transformed the healthcare industry bringing on the table several life-saving drugs. Long 60 years back, when the first antibiotic, Penicillin, came into existence, a new era of medicine with the potential to cope up with bacterial infections began. However, the...
Find More
Artios Pharma announces collaboration with Novartis to tap next-generation DDR cancer therapies Artios Pharma Limited, a leading DNA Damage Response (DDR) company exploiting synthetic lethality to create a broad pipeline of precision medicines for cancer treatment, announced a global research collaboration with ...
Find More
Over the past few, the internet and communication technology (ICT) has evolved significantly and empowered the consumer like never before. Today, the consumer has thousands of products and services available through a click of a button. Along with the increased variety/range of products, it has also saved user’s ti...
Find More
Promega Biotech Ibérica Gains Recognition for COVID-19 Response in Spain Promega Biotech Ibérica has been heralded as the business leader in Spain for its COVID-19 response. The company’s innovative approach to deal with COVID-19 and pandemic has led La Razón, a daily newspaper based in Madrid, to felicitate the...
Find More
Global Blood Therapeutics strikes a deal with Sanofi for sickle cell disease programs As Global Blood Therapeutics works to bring its sickle cell disease drug, Oxbryta, to younger patients, the company is reinforcing its pipeline with a pair of early-stage programs from Sanofi. In exchange for the global righ...
Find More
Merck, Gilead to co-develop combined HIV treatments Merck and Gilead have announced a collaboration to investigate Gilead’s investigational capsid inhibitor, lenacapavir, and Merck’s investigational nucleoside reverse transcriptase translocation inhibitor, islatravir, into a two-drug regimen. Both...
Find More
Novavax targets approval for the COVID-19 vaccine in the US Novavax is targeting a second-quarter FDA filing for emergency use of its COVID-19 vaccine. The aim hints the U.S. could join the U.K. on the list of countries to permit the vaccine in the first half of the year. The vaccine’s success in a 15,000-sub...
Find More
The Covid-19 pandemic has brought unprecedented challenges to the healthcare systems. Not just healthcare; in fact, the whole world came to a standstill. However, technology has played a crucial role in addressing some of the critical issues. The Covid-19 has accelerated the digital transformation and technological...
Find More
Bluebird suspends gene therapy trials after two sickle cell patients develop cancer Bluebird bio has stopped two clinical trials of its sickle cell disease gene therapy after participants developed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). During the pause, bluebird will assess whether the ...
Find More
Medical device manufacturing and development is a high-capital demanding endeavor and therefore the .....
Find More
Myasthenia Gravis is a chronic autoimmune neuromuscular disease responsible for weakness in the skel.....
Find More
Lyme disease is a vector-borne infectious disease that spreads primarily by the bite of a tick (also.....
Find More
Cell therapies now are often recommended to treat cancer in several ways, out of which CAR T-cell th.....
Find More
Over the last months, the world has faced one of the most unexpected challenges in the form of a nov.....
Find More
Pulmonary Arterial Hypertension (PAH) is a rare, chronic, and progressive form of Pulmonary Hyperten.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
